Terms: = Breast cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Clinical Outcome
3 results:
1. Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.
Dressler AC; Hudelist G; Fink-Retter A; Gschwantler-Kaulich D; Pfeiler G; Rosner M; Hengstschläger M; Singer CF
J Cancer Res Clin Oncol; 2013 Aug; 139(8):1349-55. PubMed ID: 23689538
[TBL] [Abstract] [Full Text] [Related]
2. IKK beta suppression of tsc1 links inflammation and tumor angiogenesis via the mTOR pathway.
Lee DF; Kuo HP; Chen CT; Hsu JM; Chou CK; Wei Y; Sun HL; Li LY; Ping B; Huang WC; He X; Hung JY; Lai CC; Ding Q; Su JL; Yang JY; Sahin AA; Hortobagyi GN; Tsai FJ; Tsai CH; Hung MC
Cell; 2007 Aug; 130(3):440-55. PubMed ID: 17693255
[TBL] [Abstract] [Full Text] [Related]
3. Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of tsc genes.
Jiang WG; Sampson J; Martin TA; Lee-Jones L; Watkins G; Douglas-Jones A; Mokbel K; Mansel RE
Eur J Cancer; 2005 Jul; 41(11):1628-36. PubMed ID: 15951164
[TBL] [Abstract] [Full Text] [Related]
